Evidence map›Paper›PMID 41458543›Full record

ArticleFrontiers in endocrinology2025

Impact of the triglyceride-glucose-neutrophil-to-lymphocyte ratio and the C-reactive protein-TyG index on cardio-renal disease in patients with type 2 diabetes.

Ying Guo, Hongjian Jia, Yan Wang, Mengyan Li, Tong Chen, Zhendong Diao, Xicheng Li, Jietao Zhang

Abstract read
In one paragraph

Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ying Guo *The Affiliated Hospital of Jining Medical University, Jining, Shandong, China.
Hongjian Jia *The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.
Yan WangThe Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.
Mengyan LiShandong Second Medical University, Weifang, Shandong, China.
Tong ChenThe Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.
Zhendong DiaoThe Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.
Xicheng LiThe Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.
Jietao ZhangThe Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Insulin resistance and systemic inflammation jointly drive deterioration of cardiorenal-metabolic function; however, how composite indices reflect disease severity remains unclear. We compared the triglyceride-glucose-neutrophil-to-lymphocyte ratio (TyG-NLR) and a C-reactive protein-TyG-based index (CTI) to examine their associations with severity outcomes in hospitalized adults with type 2 diabetes. Methods: We conducted a retrospective study of hospitalized adults with type 2 diabetes at the Affiliated Hospital of Qingdao University, classifying cardiorenal disease into four severity levels. Using ordinal logistic regression, we evaluated the independent associations of the C-reactive protein-TyG-based index (CTI) and the triglyceride-glucose neutrophil-to-lymphocyte ratio (TyG-NLR) with severity, performed trend testing (p-trend), and explored potential nonlinearity with restricted cubic splines (RCS). For robustness, we additionally fitted a partial proportional odds model (VGAM framework) and a multinomial logistic model. Relative to a base covariate model, we assessed the incremental value of these indices in terms of overall model performance (AIC, BIC, Nagelkerke R², likelihood-ratio test), discrimination (AUC), calibration (calibration plot, slope, and calibration-in-the-large [CITL]), and clinical net benefit via decision-curve analysis (DCA). Results: A total of 2, 885 patients were included. In multivariable ordinal logistic regression analysis, both higher quartiles of CTI and TyG-NLR were significantly associated with increased disease severity (CTI_Q4 vs Q1: OR = 1.59, 95% CI 1.21-2.09; TyG-NLR_Q4 vs Q1: OR = 2.14, 95% CI 1.64-2.78; both P< 0.001). The Brant test indicated partial violation of the proportional odds assumption; sensitivity analysis using a VGAM-based partial proportional odds model yielded consistent results across thresholds. Trend tests revealed a significant linear increase in disease severity across quartiles for both indices (all P for trend < 0.001).Restricted cubic spline (RCS) analysis showed a nonlinear relationship between TyG-NLR and disease severity (LRT χ²= 34.438, P < 0.001), with the risk plateauing beyond a TyG-NLR value of approximately 16.64; in contrast, CTI exhibited an approximately linear association (LRT χ² = 1.486, P = 0.476). Regarding model performance, the TyG-NLR model achieved the best overall fit (AIC = 4367, BIC = 4488, Nagelkerke R² = 0.245, LR χ² = 50.8, P = 5.3 × 10 Conclusions: In adults with type 2 diabetes, both CTI and TyG-NLR were independently associated with cardiorenal disease severity.Notably, TyG-NLR demonstrated a steeper risk gradient and modest improvements in discrimination and calibration, and it yielded slightly higher net clinical benefit across clinically relevant decision thresholds. These findings suggest potential clinical utility for risk stratification, although the overall predictive gain was moderate and requires further validation.

Indexed as

Blood GlucoseC-Reactive ProteinDiabetes Mellitus, Type 2LymphocytesNeutrophilsTriglyceridesAgedBiomarkersFemaleHumansMaleMiddle AgedRetrospective StudiesSeverity of Illness IndexBiomarkersBlood GlucoseC-Reactive ProteinTriglyceridescardio-renal-metabolic diseaseCTIinsulin resistanceordinal severitysystemic inflammationTyG-NLR

Identifiers

PMID41458543
PMCPMC12740873

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.